The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
Crossref DOI link: https://doi.org/10.1007/s12325-016-0413-7
Published Online: 2016-09-27
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
San-Miguel, Jesus F.
Einsele, Hermann
Moreau, Philippe
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation